HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B
Yazar
Boucher, Charles A.
Tabak, Fehmi
Mach, Tomasz H.
Hansen, Bettina E.
Janssen, Harry L.
Sonneveld, Milan J.
Rijckborst, Vincent
Zoutendijk, Roeland
Gerken, Guido
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]